Latest Breaking News On - Isma hachi - Page 1 : vimarsana.com

EBD Group: The Global Biopharma Community is now Actively Partnering for BIO-Europe 2023

EBD Group: The Global Biopharma Community is now Actively Partnering for BIO-Europe 2023
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Carolin clementIhre chancenIndiens wirtschaftAlexendra zempBioequity europeKarina maroccoIsma hachiBiopharm americaChristoph brojaBiotechnology innovation organizationMc servicesLife sciencesPartner at mckinsey companyBayer pharmaceuticalsCo lab berlin at bayer pharmaceuticalsStartup spotlight

EBD Group: The Global Biopharma Community is now Actively Partnering for BIO-Europe(R) 2023

EBD Group: The Global Biopharma Community is now Actively Partnering for BIO-Europe(R) 2023
bostonstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bostonstar.com Daily Mail and Mail on Sunday newspapers.

Isma hachiCarolin clementBioequity europeBiopharm americaAlexendra zempKarina maroccoChristoph brojaBayer pharmaceuticalsLife sciencesBiotechnology innovation organizationMc servicesCo lab berlin at bayer pharmaceuticalsPartner at mckinsey companyStartup spotlightScientific finder collaborateCure hub

Sandoz to move headquarters to Basel, Switzerland

As Sandoz prepares to become standalone company, the pharma firm has declared it will base itself in Basel, facilitating closer collaboration.

Switzerland generalRichard saynorIsma hachiSandoz pharmaceuticalsSandoz groupDirector emerging biopharma

European biotechs choosing Switzerland as base, research shows

The trend for European biotech companies to headquarter in Switzerland appears to be continuing, according to research.

Patrik wermelingerIsma hachiHead of management servicesInternational affairsSwiss agency for therapeutic products swissmedicBiotech reportDirector emerging biopharmaChief investment promotion officerSwitzerland globalManagement servicesSwiss agencyTherapeutic products